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Abstract
Adenoviruses are widely used for overexpressing proteins in primary mammalian cells. Incorporation of the early viral gene,
E1A, or viral cross-contamination can occur during amplification, and identification of these products is crucial as the
transcription of unwanted genetic material can impact cell function and compromise data interpretation. Here we report
methods for evaluation of contaminating adenovirus and E1 viral DNA.
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Introduction
The generation and use of adenoviruses (Ad) in physiological
research has become a routine procedure due to their ability to
increase protein expression in primary mammalian cells that
cannot be efficiently transfected with plasmid DNA. Creating
and amplifying an Ad is a time and labor intensive process;
therefore it is necessary to determine as early as possible that the
gene of interest (GOI) is free of mutations and is not
contaminated with another coding sequence. This is particularly
p e r t i n e n tw h e nc r e a t i n gm o r et h a no n eA da tat i m eu s i n gs i t e
directed mutagenesis (i.e. wild type and mutant), as it is not
possible to verify the authenticity of the final adenovirally
expressed protein using standard immunoblot techniques.
Although it is common practice to screen the Ad cosmid DNA
for errors, in our experience the stage at which Ad are most
susceptible to unwanted contamination, and therefore the most
important to screen, is during the initial formation of a viral
plaque. During this period of time a single contaminating viral
particle, i.e. from aerosolization of another Ad used in the same
sterile hood, or an Ad that is amplified in the same incubator as
the single clones, is enough to cause contamination, which may
replace expression of the intended GOI with that of the
contaminating virus. We therefore propose routine evaluation of
t h ei n i t i a lv i r a lp l a q u e ss h o u l db ed o n eu s i n gas i m p l eP C R -
b a s e dm e t h o da n ds u g g e s tr o u t i ne decontamination of incuba-
tors used to amplify Ad.
Refined vector systems, such as AdEasy, make Ad production a
relatively straight forward procedure. This system is based on the
human Ad serotype 5 genome and belongs to the so called 2
nd
generation Ad constructs that omit the early viral genes, E1 and
E3, but maintain the viral packaging signal and inverted terminal
repeat (ITR) required for viral transcription. The benefits of using
2
nd generation Ad are that they can accommodate a GOI up to
7.5 kb. Using a bacterial plasmid containing left and right arm
flanking homology domains, the GOI is inserted into the site of the
disrupted E1A by homologous recombination. E1A is a viral
transcription factor required for induction of early genes necessary
for viral replication, including E1B and E2 [1,2], progression of
the cell cycle, and inhibition of apoptosis [2]. E3, though not
technically required for viral replication, plays an important role in
suppression of host immunity [3,4]. In the absence of E1A and E3,
the recombinant Ad can infect but not replicate in most cells.
Since 2
nd generation Ad lack E1 and E3, rendering them non-
replicative, they must be amplified in packaging cell lines that
express E1 gene products. In HEK293 cells, which are
transformed with bases 1–4355 (containing full-length E1) of
sheared human Ad5 genome, the Ad with GOI insert can be
packaged and amplified via E1A and E3 supplied in trans.
However, because many vector systems maintain significant
portions of the human Ad5 genome, single or double homologous
recombination events between the transformed HEK293 cells and
the viral cosmid can occur, resulting in the production of
replication competent Ad contamination (Figure 1). Though rare
in early passages of adenovirus, the probability of replication
competent Ad contamination increases with large-scale amplifica-
tion [5], a phenomenon that has led to the decline of HEK293
cells in adenoviral production for clinical usage but has not
translated to the basic science laboratory. Even optimized
protocols fail to warn about the possibility of recombination with
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during the amplification process via a simple PCR method.
Materials and Methods
Ad constructs were prepared and cesium chloride purification
was performed according to the previously reported methods
[6,7].
Isolation of Ad DNA and PCR for E1A
DNA was isolated from cesium chloride-purified Ad using
proteinase K extraction with the RedExtract-N-Amp Tissue PCR
kit (Sigma). Isolated Ad DNA was tested for the presence of E1A
contamination using the following primer sets as reported by
Lavine et al. and Kuwano et al. [8,9]:
E1A nested outer primers: 59-CTGCCACGGAGGTGTTAT-
TACC-39 and 59-CTCAGGTTCAGACACAGGACCT-39
E1A nested inner primers: 59-GAACCACCTACCCTTCAC-
GAACTG-39 and 59-GTGGCAGGTAAGATCGATCACCTC-39.
E1A primer set: 59-TATGCCAAACCTTGTACCGGAGGT-
39 and 59-CCGGGGTGCTCCACATAATCT-39
Nested PCR reactions were performed sequentially. All
reactions were performed using REDExtract-N-Amp PCR
Reaction Mix containing JumpStart Taq polymerase (Sigma
Aldrich) using an Endurance TC-512 Thermocycler (Techne
Inc.). Primers were added at a final concentration of 5 mMt o1 6
PCR Reaction Mix containing 4 ml DNA for a final volume of
20 ml. Nested PCR was performed with initial denaturation at 94
degrees for 3 mins followed by 30 cycles with denaturation for
1 min at 94 degrees, annealing for 45 secs at 63 degrees and
extension for 1 min at 72 degrees. Final extension was held for
10 mins at 72 degrees. Confirmation of PCR products was
performed using the E1A primer set and was performed with
initial denaturation at 94 degrees for 3 mins followed by 30 cycles
with denaturation for 1 min at 94 degrees, annealing for 30 secs at
60 degrees and extension for 45 secs at 72 degrees. PCR products
were analyzed on a 1% agarose gel containing 200 ng/ml
ethidium bromide (Bio-Rad) in 16 TAE buffer. Bands were
visualized using the Bio-Rad Gel-Doc system.
Isolation of Ad DNA and PCR for GOI
DNA was isolated from early amplifications by taking a small
portion of the cell suspension before freeze/thawing, obtaining a
cell pellet by centrifugation (5 min, 1000 rcf) and performing
proteinase K extraction with the RedExtract-N-Amp Tissue PCR
kit (Sigma).
Primer I (within affinity tag): 59-CAAATGGGTCGG-
GATCTGTA-39
Primer I (within pshuttle-CMV): 59- ACCGTCAGATCCGC-
TAGAGA- 39
Primer II (downstream GOI): 59-GATCCGGTGGATCGGA-
TAAA-39
Primer III (Sequencing Primer): 59-GATCCAGAAC-
CATTTTGTG-39
Primers were added at a final concentration of 0.5 mMt o1 6
PCR Reaction Mix containing 3–7 ml DNA (depending on viral
titer). PCR reaction was performed with an initial denaturation at
94 degrees for 3 mins and annealing at 60 degrees for 3 min,
followed by 30 cycles with denaturation for 1 min at 94 degrees,
annealing for 30 secs at 60 degrees and extension for 30 secs at 72
degrees. Final extension was held for 10 mins at 72 degrees. 5 mlo f
PCR product was analyzed for size as described above. The
remaining PCR reaction was processed with a PCR cleanup kit
(Qiagen) and submitted for sequencing using the Tufts sequencing
core facility.
Results and Discussion
To specifically amplify only GOI and not the HEK cell
endogenous gene, we designed a set of PCR primers (Figure 2A),
where Primer I binds either at the junction between the upstream
Figure 1. Homologous recombination of HEK293 Ad5 genomic DNA with the Ad construct. HEK293 cells contain bases 1–4345 of Human
Ad serotype 5 genome, including the packaging signal (y) and E1 region. Overlapping Ad5 sequences in 2
nd generation Ad constructs can undergo
single or double homologous recombination to yield replication competent Ad.
doi:10.1371/journal.pone.0023160.g001
Figure 2. Contamination of Ad constructs during replication.
(A) Primer locations for PCR of Ad and subsequent sequencing. Primer I
and primer III ensure PCR of viral DNA by overlapping either with an
affinity tag or part of the construct sequence. (B) Procedure used for
sequencing Ad. (C) Sequencing results from early stage Ad amplification
demonstrating contamination of the GOI.
doi:10.1371/journal.pone.0023160.g002
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sequence of the GOI. Primer II binds at the sequence downstream
of GOI and ensures amplification of only the Ad sequence. The
PCR products were checked for specific amplification and size via
agarose gel separation, and DNA sequencing services were used to
determine the authenticity of the PCR product (Figure 2B).
Depending on the size of GOI, one or more sequencing primers
(Primer III) should be designed to cover the entire sequence. When
using multiple primers, contiguous primers should be designed to
generate overlapping sequences. By using this method we
identified a contaminant during an attempt to create an Ad. In
this particular case we found 3 different populations of Ad from
the initial viral plaque. In Figure 2C, the chromatograms show 1)
the desired mutation C118, 2) a mixed virus population of C118
contaminated with S118, and 3) a completely contaminated clone
with S118. With this PCR-based method it is not only possible to
detect cross-contamination but also accidental mutation that can
happen while the virus is amplified from a single copy to up to 10
12
viral particles per ml. This screening technique ensures that only
viral clones with the correct DNA sequence are propagated and
provides assurance that results obtained with Ad can be accurately
interpreted.
Following amplification in HEK293 cells, high titer virus can
be purified using the cesium chloride density centrifugation
method, which yields high purity viral stock. We propose
routine screening of this stock for the presence of contaminating
replication competent Ad. Traditional sequencing protocols for
the viral genome rely on reverse transcription of mRNA
produced in Ad transfected cells; however, using proteinase K
extraction, we purified viral DNA and directly tested for E1A
using PCR. We tested four viruses amplified in HEK293 cells
and found E1A contamination present in one Ad stock
(Figure 3A). Using the contaminated Ad and an Ad containing
the same GOI but no E1A contamination, we infected human
aortic endothelial cells (HAEC) and measured cellular migration
using a tube formation assay in Matrigel-coated plates. Ad
contaminated with E1A showed a marked increase in tube
formation over the same virusw i t h o u tE 1 A( F i g u r e3 B )i n
response to VEGF, demonstrating the possible confounding
impact of E1A contamination in cell culture studies. Testing for
E1A contamination after purification of Ad should be standard
practice in order to ensure the integrity of results in Ad-
transduced cells.
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